SILK SURGERY TECHNOLOGY TRANSFER CEREMONY
On March 10, 2025, in Hanoi, Japan International Eye Hospital and Johnson & Johnson (USA) officially introduced the SILK refractive surgery technology, representing a major step forward in refractive error treatment in Vietnam. The event was attended by top executives from both companies, leading ophthalmologists, and healthcare professionals and medical experts.
SILK (Smooth Incision Lenticule Keratomileusis) is currently the most advanced laser refractive surgery technique, utilizing 5th-generation Femtosecond laser technology with low energy output, ultra-fast pulse delivery, and ultra-small spot size. SILK enables the creation of a bi-convex lenticule, delivering a smooth, gentle surgical experience while ensuring optimal corneal preservation and faster healing times.
Expert insights on SILK surgery
At the event, Dr. Vu Anh Tuan, Medical Director of Japan International Eye Hospital, shared:
“We are thoroughly convinced by the outstanding benefits that SILK offers our patients. It represents a major advancement in refractive surgery, enhancing surgical precision, corneal protection, and accelerating recovery.”
He further emphasized that SILK not only ensures optimal safety but also significantly improves patients visual quality. With the advanced ELITA laser system, SILK promises to usher in a new chapter in refractive surgery.
Johnson & Johnson - A Giant In Healthcare
As one of the world’s leading healthcare corporations, Johnson & Johnson continues to pioneer innovative medical solutions that elevate treatment standards. With over 130 years of experience, the corporation has consistently advanced technology to provide safe, effective, and cutting-edge treatments to patients worldwide.
In the field of ophthalmology, SILK stands out as one of Johnson & Johnson’s most remarkable achievements. This technology not only redefines next-generation laser refractive surgery but also delivers a gentle, cornea-preserving experience—helping patients naturally achieve clear, sharp vision.
Japan International Eye Hospital – A Pioneer in Cutting-Edge Ophthalmic Treatment
The SILK refractive surgery technology provides a safe, effective, and comfortable treatment option, opening new doors for patients with refractive errors in Vietnam.
By being the first to implement SILK, Japan International Eye Hospital continues to enhance treatment outcomes for refractive errors and reaffirms its commitment to constantly adopting the most modern ophthalmic technologies—ensuring the highest quality of care for its patients.
With Japanese service standards, the hospital always puts patients at the center, staying true to its core philosophy: "For the patients and their future"—a principle that has been upheld for over 10 years.
